Medications

Researchers race to develop Paxlovid replacement

Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.

Genetics

Immune cells identified as key players in brain health

Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role of immune cells called macrophages in lipid-rich tissues like the brain, advancing our understanding ...

page 1 from 2